Perceptive Advisors Llc

Insider Reports History

Entity: Company
Location: 51 Astor Place, 10 Th Floor, New York, NY
Signature: /s/ Joseph Edelman - for Perceptive Advisors LLC, By: Joseph Edelman, its managing member
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Perceptive Advisors Llc:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Crinetics Pharmaceuticals, Inc.	10%+ Owner	Common Stock	5.32M	$200M	$37.65	Apr 18, 2022	Indirect
VBI Vaccines Inc/BC	10%+ Owner	Common Stock	41.4M	$137M	$3.31	Apr 6, 2023	Indirect
SOLENO THERAPEUTICS INC	10%+ Owner	Common Stock	3.07M	$112M	$36.49	Sep 28, 2023	Indirect
ALBIREO PHARMA, INC.	10%+ Owner	Common Stock	1.94M	$85M	$43.80	Oct 13, 2022	Indirect
ADMA BIOLOGICS, INC.	10%+ Owner	Common Stock	13.3M	$59.9M	$4.52	Sep 30, 2021	Indirect
Astria Therapeutics, Inc.	Director	Common Stock	4.87M	$58.9M	$12.09	Feb 1, 2024	Indirect
Verrica Pharmaceuticals Inc.	10%+ Owner	Common Stock	7.1M	$51.4M	$7.24	Dec 29, 2023	Indirect
MeiraGTx Holdings plc	Director, 10%+ Owner	Ordinary Shares	12.5M	$50.1M	$4.00	Aug 12, 2024	Indirect
Solid Biosciences Inc.	Director, 10%+ Owner	Common Stock	11.8M	$47.7M	$4.03	Feb 19, 2025	Indirect
Acrivon Therapeutics, Inc.	10%+ Owner	Common Stock	5.36M	$45.6M	$8.50	Apr 11, 2024	Indirect
Aldeyra Therapeutics, Inc.	10%+ Owner	Common Stock	9.28M	$44M	$4.74	Apr 5, 2024	Indirect
Lyra Therapeutics, Inc.	Director, 10%+ Owner	Common Stock	11.5M	$34M	$2.96	May 31, 2023	Indirect
AGILE THERAPEUTICS INC	10%+ Owner	Common Stock	21.7M	$18.4M	$0.85	Oct 13, 2021	Indirect
Athira Pharma, Inc.	Director, 10%+ Owner	Common Stock	5.4M	$12.9M	$2.38	Dec 29, 2023	Indirect
VYNE Therapeutics Inc.	10%+ Owner	Common Stock	4.94M	$11.3M	$2.28	Aug 16, 2021	Indirect
Astria Therapeutics, Inc.	Director	Pre-funded Warrants (right to buy)	921K	$6M	$6.51	Oct 16, 2023	Indirect
CARGO Therapeutics, Inc.	Former 10% Owner	Common Stock	333K	$5M	$15.00	Nov 14, 2023	Indirect
Rain Therapeutics Inc.	10%+ Owner	Common Stock	2.49M	$3.01M	$1.21	Oct 12, 2021	Indirect
IsoPlexis Corp	10%+ Owner	Common Stock	3.55M	$2.58M	$0.73	Oct 12, 2021	By Perceptive Life Sciences Master Fund, Ltd.
Astria Therapeutics, Inc.	Director	Common Warrants (right to buy)	345K	$2.25M	$6.51	Oct 16, 2023	Indirect
CHEMBIO DIAGNOSTICS, INC.	10%+ Owner	Common Stock	3.67M	$1.65M	$0.45	Apr 4, 2023	Indirect
Quotient Ltd	10%+ Owner	Ordinary Shares, nil par value	7.95M	$636K	$0.08	Oct 31, 2022	Indirect
IsoPlexis Corp	10%+ Owner	Common Stock	336K	$244K	$0.73	Oct 12, 2021	By Perceptive Credit Holdings III, LP
IsoPlexis Corp	10%+ Owner	Common Stock	205K	$149K	$0.73	Oct 12, 2021	By PCOF EQ AIV III, LP
LianBio	Director, 10%+ Owner	Ordinary Shares	17.1K	$81.3K	$4.76	Feb 15, 2024	Indirect
Cerevel Therapeutics Holdings, Inc.	Director	Common Stock	0	$0	$41.54	Feb 20, 2024	Indirect
Adagio Medical Holdings, Inc.	Director, 10%+ Owner	Common Stock	9.68M			Jan 22, 2025	Direct
Orchestra BioMed Holdings, Inc.	10%+ Owner	Common Stock, $0.0001 par value per share	4.59M			Jul 11, 2024	Indirect
LianBio	Director, 10%+ Owner	American Depository Shares	3.73M			Feb 15, 2024	Indirect
Landos Biopharma, Inc.	10%+ Owner	Pre-funded Warrant	3.64M			Jan 10, 2023	Indirect
LEAP THERAPEUTICS, INC.	10%+ Owner	Warrants (right to buy)	3.51M			Sep 24, 2021	Indirect
AGILE THERAPEUTICS INC	10%+ Owner	Warrants (right to buy)	2.69M			Oct 13, 2021	Indirect
Lyra Therapeutics, Inc.	Director, 10%+ Owner	Common Stock Purchase Warrant	1.81M			May 31, 2023	Indirect
SOLENO THERAPEUTICS INC	10%+ Owner	Pre-funded warrants (right to buy)	250K			Sep 28, 2023	Indirect
Adagio Medical Holdings, Inc.	Director, 10%+ Owner	Common Stock	201K			Jan 22, 2025	Indirect
MeiraGTx Holdings plc	Director, 10%+ Owner	Restricted Share Units	45K			Jun 6, 2024	Indirect
Nautilus Biotechnology, Inc.	Director, 10%+ Owner	Stock Option (Right to Buy)	45K			Jun 14, 2024	Indirect
Solid Biosciences Inc.	Director, 10%+ Owner	Director Stock Option (Right to Buy)	34.4K			Jun 11, 2024	Indirect
CARGO Therapeutics, Inc.	Former 10% Owner	Series A-1 Convertible Preferred Stock	0			Nov 14, 2023	Indirect
IsoPlexis Corp	10%+ Owner	Series D Redeemable Convertible Preferred Stock	0			Oct 12, 2021	By PCOF EQ AIV III, LP
IsoPlexis Corp	10%+ Owner	Series D Redeemable Convertible Preferred Stock	0			Oct 12, 2021	By Perceptive Credit Holdings III, LP
IsoPlexis Corp	10%+ Owner	Series D Redeemable Convertible Preferred Stock	0			Oct 12, 2021	By Perceptive Life Sciences Master Fund, Ltd.
LianBio	Director, 10%+ Owner	Stock Option (Right to Buy)	0			Feb 15, 2024	Indirect

Previous1Next

Showing 1 to 43 of 43 entries

Insider Reports Filed by Perceptive Advisors Llc

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
SLDB	Solid Biosciences Inc.	Feb 19, 2025	1	$20.2M	4	Feb 21, 2025	Director, 10%+ Owner
ADGM	Adagio Medical Holdings, Inc.	Jan 22, 2025	1	$0	4	Feb 14, 2025	Director, 10%+ Owner
MGTX	MeiraGTx Holdings plc	Aug 12, 2024	1	$5M	4	Aug 14, 2024	Director, 10%+ Owner
ADGM	Aja Holdco, Inc.	Jul 31, 2024	0	$0	3	Aug 1, 2024	Director, 10%+ Owner
OBIO	Orchestra BioMed Holdings, Inc.	Jul 11, 2024	0	$0	3	Jul 17, 2024	10%+ Owner
VAPO	VAPOTHERM INC	Jun 17, 2024	0	$0	3	Jun 27, 2024	10%+ Owner
NAUT	Nautilus Biotechnology, Inc.	Jun 14, 2024	1	$0	4	Jun 17, 2024	Director, 10%+ Owner
SLDB	Solid Biosciences Inc.	Jun 11, 2024	1	$0	4	Nov 19, 2024	Director, 10%+ Owner
MGTX	MeiraGTx Holdings plc	Jun 6, 2024	1	$0	4	Jun 7, 2024	Director, 10%+ Owner
ACRV	Acrivon Therapeutics, Inc.	Apr 11, 2024	1	$20M	4	Apr 15, 2024	10%+ Owner
ALDX	Aldeyra Therapeutics, Inc.	Apr 4, 2024	2	$834K	4	Apr 8, 2024	10%+ Owner
ALDX	Aldeyra Therapeutics, Inc.	Apr 1, 2024	3	$1.93M	4	Apr 3, 2024	10%+ Owner
CERE	Cerevel Therapeutics Holdings, Inc.	Feb 20, 2024	1	$0	4	Feb 21, 2024	Director
LIAN	LianBio	Feb 15, 2024	6	-$3	4	Feb 20, 2024	Director, 10%+ Owner
ATXS	Astria Therapeutics, Inc.	Feb 1, 2024	1	$30M	4	Feb 5, 2024	Director
SLDB	Solid Biosciences Inc.	Jan 11, 2024	1	$18.9M	4	Jan 12, 2024	Director, 10%+ Owner
VRCA	Verrica Pharmaceuticals Inc.	Dec 27, 2023	3	$2.31M	4	Dec 29, 2023	10%+ Owner
ATHA	Athira Pharma, Inc.	Dec 27, 2023	3	$1.46M	4	Dec 29, 2023	Director, 10%+ Owner
VRCA	Verrica Pharmaceuticals Inc.	Dec 21, 2023	3	$3.26M	4	Dec 26, 2023	10%+ Owner
ATXS	Astria Therapeutics, Inc.	Dec 21, 2023	1	$4.59M	4	Dec 22, 2023	Director
VRCA	Verrica Pharmaceuticals Inc.	Dec 15, 2023	3	$6.94M	4	Dec 19, 2023	10%+ Owner
CRGX	CARGO Therapeutics, Inc.	Nov 14, 2023	4	$10M	4	Nov 14, 2023	Former 10% Owner
CRGX	CARGO Therapeutics, Inc.	Nov 9, 2023	0	$0	3	Nov 9, 2023	10%+ Owner
ALDX	Aldeyra Therapeutics, Inc.	Oct 16, 2023	2	-$4.45M	4	Oct 18, 2023	10%+ Owner
ATXS	Astria Therapeutics, Inc.	Oct 16, 2023	6	$26M	4	Oct 18, 2023	Director
CERE	Cerevel Therapeutics Holdings, Inc.	Oct 16, 2023	1	$20M	4	Oct 17, 2023	Director
SLNO	SOLENO THERAPEUTICS INC	Sep 26, 2023	16	$20.1M	4	Sep 28, 2023	10%+ Owner
LIAN	LianBio	Jun 21, 2023	2	$0	4	Jun 23, 2023	Director, 10%+ Owner
NAUT	Nautilus Biotechnology, Inc.	Jun 15, 2023	1	$0	4	Jun 20, 2023	Director
MGTX	MeiraGTx Holdings plc	Jun 8, 2023	2	$0	4	Jun 12, 2023	Director, 10%+ Owner
SLDB	Solid Biosciences Inc.	Jun 6, 2023	1	$0	4	Jun 8, 2023	Director, 10%+ Owner
SLNO	SOLENO THERAPEUTICS INC	Jun 2, 2023	3	$854K	4	Jun 6, 2023	10%+ Owner
LYRA	Lyra Therapeutics, Inc.	May 31, 2023	2	$9M	4	Jun 2, 2023	Director, 10%+ Owner
SLNO	SOLENO THERAPEUTICS INC	May 30, 2023	3	$188K	4	Jun 1, 2023	10%+ Owner
SLNO	SOLENO THERAPEUTICS INC	May 24, 2023	3	$450K	4	May 26, 2023	10%+ Owner
SLNO	SOLENO THERAPEUTICS INC	May 19, 2023	3	$406K	4	May 23, 2023	10%+ Owner
SLNO	SOLENO THERAPEUTICS INC	May 11, 2023	0	$0	3	May 18, 2023	10%+ Owner
MGTX	MeiraGTx Holdings plc	May 5, 2023	1	$25M	4	May 15, 2023	Director, 10%+ Owner
CEMI	CHEMBIO DIAGNOSTICS, INC.	Apr 4, 2023	0	$0	3	Apr 6, 2023	10%+ Owner
VBIV	VBI Vaccines Inc/BC	Apr 4, 2023	3	-$1.48M	4	Apr 6, 2023	10%+ Owner
LABP	Landos Biopharma, Inc.	Jan 10, 2023	2	$16.7M	4	Jan 11, 2023	10%+ Owner
ATXS	Astria Therapeutics, Inc.	Dec 19, 2022	1	$10M	4	Dec 21, 2022	Director
SLDB	Solid Biosciences Inc.	Dec 13, 2022	1	$0	4	Dec 15, 2022	Director, 10%+ Owner
SLDB	Solid Biosciences Inc.	Dec 2, 2022	3	$15.2M	4	Dec 6, 2022	Director, 10%+ Owner
ACRV	Acrivon Therapeutics, Inc.	Nov 17, 2022	0	$0	3	Nov 18, 2022	10%+ Owner
QTNT	Quotient Ltd	Oct 31, 2022	1	-$660K	4	Nov 2, 2022	10%+ Owner
ALBO	ALBIREO PHARMA, INC.	Oct 11, 2022	7	-$9.51M	4	Oct 13, 2022	10%+ Owner
LIAN	LianBio	Aug 18, 2022	1	$2.4M	4	Aug 22, 2022	Director, 10%+ Owner
CERE	Cerevel Therapeutics Holdings, Inc.	Aug 16, 2022	2	$150M	4	Aug 18, 2022	Director
ALDX	Aldeyra Therapeutics, Inc.	Aug 9, 2022	2	$868K	4	Aug 11, 2022	10%+ Owner
ALDX	Aldeyra Therapeutics, Inc.	Aug 8, 2022	1	$702K	4	Aug 10, 2022	10%+ Owner
ALDX	Aldeyra Therapeutics, Inc.	Aug 5, 2022	1	$980K	4	Aug 9, 2022	10%+ Owner
ALDX	Aldeyra Therapeutics, Inc.	Aug 4, 2022	1	$587K	4	Aug 8, 2022	10%+ Owner
ALDX	Aldeyra Therapeutics, Inc.	Aug 3, 2022	1	$584K	4	Aug 5, 2022	10%+ Owner
ALDX	Aldeyra Therapeutics, Inc.	Aug 2, 2022	1	$2.31M	4	Aug 4, 2022	10%+ Owner
ALDX	Aldeyra Therapeutics, Inc.	Aug 1, 2022	1	$728K	4	Aug 3, 2022	10%+ Owner
ALDX	Aldeyra Therapeutics, Inc.	Jul 29, 2022	1	$1.12M	4	Aug 2, 2022	10%+ Owner
ALDX	Aldeyra Therapeutics, Inc.	Jul 28, 2022	1	$597K	4	Aug 1, 2022	10%+ Owner
VRCA	Verrica Pharmaceuticals Inc.	Jul 5, 2022	1	$3M	4	Jul 5, 2022	10%+ Owner
ATHA	Athira Pharma, Inc.	Jun 29, 2022	2	$4.1M	4	Jul 1, 2022	Director, 10%+ Owner
LIAN	LianBio	Jun 23, 2022	2	$0	4	Jun 27, 2022	Director, 10%+ Owner
NAUT	Nautilus Biotechnology, Inc.	Jun 15, 2022	1	$0	4	Jun 17, 2022	Director, 10%+ Owner
MGTX	MeiraGTx Holdings plc	Jun 7, 2022	2	$0	4	Jun 13, 2022	Director, 10%+ Owner
SLDB	Solid Biosciences Inc.	Jun 7, 2022	1	$0	4	Jun 9, 2022	Director, 10%+ Owner
LIAN	LianBio	May 26, 2022	1	$216K	4	May 27, 2022	Director, 10%+ Owner
LIAN	LianBio	May 23, 2022	3	$442K	4	May 25, 2022	Director, 10%+ Owner
ATHA	Athira Pharma, Inc.	May 20, 2022	1	$0	4	May 27, 2022	Director, 10%+ Owner
CRNX	Crinetics Pharmaceuticals, Inc.	Apr 18, 2022	1	$3.5M	4	Apr 18, 2022	10%+ Owner
LYRA	Lyra Therapeutics, Inc.	Apr 12, 2022	1	$25M	4	Apr 14, 2022	Director, 10%+ Owner
NAUT	Nautilus Biotechnology, Inc.	Dec 8, 2021	1	$1.07M	4	Dec 10, 2021	Director
VBIV	VBI Vaccines Inc/BC	Dec 1, 2021	1	-$8.96M	4	Dec 3, 2021	10%+ Owner
LIAN	LianBio	Nov 3, 2021	2	$36.3M	4	Nov 5, 2021	Director, 10%+ Owner
LIAN	LianBio	Nov 1, 2021	12	$3.21M	4	Nov 3, 2021	Director, 10%+ Owner
LIAN	LianBio	Oct 29, 2021	0	$0	3	Oct 29, 2021	Director, 10%+ Owner
CRNX	Crinetics Pharmaceuticals, Inc.	Oct 25, 2021	1	$23.8M	4	Oct 25, 2021	10%+ Owner
AGRX	AGILE THERAPEUTICS INC	Oct 13, 2021	2	$4.87M	4	Oct 15, 2021	10%+ Owner
ISO	IsoPlexis Corp	Oct 12, 2021	7	$12.8M	4	Oct 14, 2021	10%+ Owner
RAIN	Rain Therapeutics Inc.	Oct 7, 2021	7	-$667K	4	Oct 13, 2021	10%+ Owner
ISO	IsoPlexis Corp	Oct 7, 2021	0	$0	3	Oct 7, 2021	10%+ Owner
ADMA	ADMA BIOLOGICS, INC.	Sep 28, 2021	3	-$299K	4	Sep 30, 2021	10%+ Owner
ADMA	ADMA BIOLOGICS, INC.	Sep 24, 2021	2	-$623K	4	Sep 29, 2021	10%+ Owner
LPTX	LEAP THERAPEUTICS, INC.	Sep 24, 2021	1	$10M	4	Sep 28, 2021	10%+ Owner
ADMA	ADMA BIOLOGICS, INC.	Sep 23, 2021	1	-$991K	4	Sep 28, 2021	10%+ Owner
LABP	Landos Biopharma, Inc.	Aug 27, 2021	1	$0	4	Aug 31, 2021	Director, 10%+ Owner
CERE	Cerevel Therapeutics Holdings, Inc.	Aug 26, 2021	1	$2.06M	4	Aug 31, 2021	Director
CERE	Cerevel Therapeutics Holdings, Inc.	Aug 23, 2021	3	$4.83M	4	Aug 25, 2021	Director
ADMA	ADMA BIOLOGICS, INC.	Aug 17, 2021	3	-$2.33M	4	Aug 19, 2021	10%+ Owner
VYNE	VYNE Therapeutics Inc.	Aug 16, 2021	1	-$435K	4	Aug 18, 2021	10%+ Owner
VYNE	VYNE Therapeutics Inc.	Aug 13, 2021	1	-$460K	4	Aug 17, 2021	10%+ Owner
VYNE	VYNE Therapeutics Inc.	Aug 12, 2021	1	-$756K	4	Aug 16, 2021	10%+ Owner
CERE	Cerevel Therapeutics Holdings, Inc.	Jul 7, 2021	1	$5M	4	Jul 9, 2021	Director
VBIV	VBI Vaccines Inc/BC	Jun 29, 2021	2	-$2.46M	4	Jun 30, 2021	10%+ Owner
MGTX	MeiraGTx Holdings plc	Jun 10, 2021	2	$0	4	Jun 14, 2021	Director, 10%+ Owner
VBIV	VBI Vaccines Inc/BC	Jun 9, 2021	6	-$1K	4	Jun 11, 2021	10%+ Owner
NAUT	ARYA Sciences Acquisition Corp III	Jun 3, 2021	1	$3.32M	4	Jun 3, 2021	Director
ATHA	Athira Pharma, Inc.	May 28, 2021	1	$0	4	Jun 1, 2021	Director
NAUT	Nautilus Biotechnology, Inc.	May 24, 2021	3	$55.1M	4	Jun 11, 2021	Former Director
NAUT	ARYA Sciences Acquisition Corp III	May 20, 2021	1	$1.61M	4	May 24, 2021	Director
NAUT	ARYA Sciences Acquisition Corp III	May 20, 2021	0	$0	3	May 24, 2021	Director
VYNE	VYNE Therapeutics Inc.	May 6, 2021	1	-$3.67M	4	May 7, 2021	10%+ Owner